Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -2 of 2
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/10/2007
 
First Published:
6/1/2000
1.
Phase I Study of Melphalan and Buthionine Sulfoximine Followed By Autologous Bone Marrow or Peripheral Blood Stem Cell Support in Children With Resistant or Recurrent High-Risk Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Over 9 months to 30 years
Other
NANT-99-02
68, N99-02, CHLA-LA-NANT-99-02, CHLA-CCI-00.020, NCT00005835
First Published:
4/16/2008
2.
Phase I Study of Buthionine Sulfoximine in Combination With Normothermic Isolated Limb Infusion of Melphalan in Patients With Persistent or Recurrent Stage IIIB or IIIC In-Transit Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
DUMC-PRO00001793
Pro00001793, NCT00661336
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute